Scars Clinical Trial
Official title:
The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar
Verified date | May 2018 |
Source | Region Skane |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The Effect of Cesarean Operative Technique on the Occurrence of Large Hysterotomy Scar Defects.
Status | Completed |
Enrollment | 122 |
Est. completion date | October 31, 2017 |
Est. primary completion date | December 1, 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
inclusion criteria: - = 18 years old - gestational age = 37 gestational weeks - cervical dilatation =5 cm, - no previous uterine surgery other than cone biopsy, loop electrosurgical excision procedure, dilatation and curettage, or dilatation and evacuation, undergoing emergency caesarean section. exclusion criteria: • need of immediate caesarean section, defined as delivery of the baby within 20 minutes. |
Country | Name | City | State |
---|---|---|---|
Sweden | Skåne University Hospital Malmö | Malmö |
Lead Sponsor | Collaborator |
---|---|
Region Skane |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | large defect | occurrence of large defects in uterine cesarean scar are detected by ultrasound and are assessed by the percentage of patients who have large defects in uterine cesarean scar | 6 months | |
Secondary | APGAR score | APGAR score measured at 1 and 5 minute after delivery. The five criteria are summarized using words chosen to form a backronym (Appearance, Pulse, Grimace, Activity, Respiration).The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10. | 1 and 5 minute after delivery | |
Secondary | blood loss | estimated blood loss during surgery is measured in terms of mL | 1 hour | |
Secondary | difficulties at delivery of fetus | difficulties at delivery of fetus at caesarean are assessed by the percentage of patients when surgeons experience difficulties at delivery of fetus at caesarean | 1 hour | |
Secondary | postoperative infection | postoperative infection after caesarean section is assessed by the percentage of patients who develop this complication | 8 weeks | |
Secondary | readmission to the hospital | readmission to the hospital due to need of re-operation is assessed by the percentage of patients who have re-operation after caesarean | 8 weeks | |
Secondary | miscarriage | occurrence of miscarriage in subsequent pregnancy is assessed by the percentage of patients who have miscarriages in subsequent pregnancy | up to 8 years | |
Secondary | scar pregnancy | occurrence of scar pregnancy in subsequent pregnancy is assessed by the percentage of patients who have scar pregnancy after the index caesarean | up to 8 years | |
Secondary | placenta previa/accreta | occurrence of placenta previa/accreta in subsequent pregnancy is assessed by the percentage of patients who have placenta previa/accreta in subsequent pregnancy | up to 8 years | |
Secondary | uterina rupture/uterine dehiscence | occurrence of uterine rupture/uterine dehiscence in subsequent labour is assessed by the percentage of patients who have uterine rupture/uterine dehiscence in subsequent labour | up to 8 years | |
Secondary | vaginal delivery after caesarean | success rate of vaginal delivery after caesarean is assessed by the percentage of patients who delivered vaginally after the index caesarean | up to 8 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04806594 -
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.
|
N/A | |
Completed |
NCT01700595 -
Preexpanded Perforator Flaps in Children
|
N/A | |
Recruiting |
NCT03782038 -
Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars
|
N/A | |
Recruiting |
NCT06202274 -
Clinical Study to Evaluate the Safety and Efficacy of Candela Technology
|
N/A | |
Not yet recruiting |
NCT02590042 -
Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction
|
Phase 1 | |
Completed |
NCT01932359 -
Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study
|
N/A | |
Unknown status |
NCT00969475 -
The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure
|
N/A | |
Recruiting |
NCT06021275 -
Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars
|
N/A | |
Recruiting |
NCT02195063 -
Survey Study for Pain Management, Wound Care, Scar Care or UDT
|
Phase 4 | |
Terminated |
NCT00803140 -
Cutaneous Scarring of Scalpel Versus Cautery
|
N/A | |
Not yet recruiting |
NCT04593706 -
Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars)
|
N/A | |
Recruiting |
NCT05847530 -
Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions
|
N/A | |
Withdrawn |
NCT01350739 -
The Umbilical Access in Laparoscopic Surgery
|
N/A | |
Completed |
NCT02145130 -
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
|
Phase 1 | |
Completed |
NCT01358838 -
Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars
|
N/A | |
Completed |
NCT03880058 -
Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance
|
Phase 1/Phase 2 | |
Recruiting |
NCT05528328 -
Post-surgical Scars After the Use of CACIPLIQ20
|
Phase 3 | |
Completed |
NCT00450775 -
Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars
|
Phase 4 | |
Completed |
NCT00580736 -
Optical Clearing of the Skin in Conjunction With Laser Treatments
|
Phase 1 | |
Withdrawn |
NCT04269317 -
Clinical Study to Evaluate the Safety and Effectiveness of the Treatment With Tixel C on Acne Scars
|
N/A |